What is considered a high-intensity statin (HMG-CoA reductase inhibitor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2025 • View editorial policy

From the Guidelines

High intensity statins are medications that reduce LDL cholesterol by 50% or more from baseline levels, and according to the most recent guidelines, these include atorvastatin at doses of 40-80 mg daily and rosuvastatin at doses of 20-40 mg daily 1.

Key Characteristics of High Intensity Statins

  • Reduce LDL cholesterol by 50% or more from baseline levels
  • Include atorvastatin at doses of 40-80 mg daily and rosuvastatin at doses of 20-40 mg daily
  • Typically prescribed for patients with established atherosclerotic cardiovascular disease, those with very high LDL cholesterol levels (190 mg/dL or higher), or patients with diabetes plus multiple cardiovascular risk factors ### Mechanism of Action and Side Effects
  • Work by inhibiting HMG-CoA reductase, an enzyme crucial for cholesterol production in the liver, thereby significantly reducing cholesterol synthesis
  • May cause side effects including muscle pain, liver enzyme elevations, and slightly increased risk of diabetes
  • Regular monitoring of liver function and muscle symptoms is recommended when taking these medications ### Clinical Use and Recommendations
  • High intensity statins are recommended for patients who require significant reduction in LDL cholesterol to reduce the risk of cardiovascular events
  • The choice of statin and dose should be individualized based on the patient's risk factors, medical history, and potential for adverse effects
  • Patients should be monitored regularly for side effects and adjustments made to their treatment plan as needed 2, 3.

From the FDA Drug Label

For patients that require a high-intensity statin or are unable to achieve their LDL-C goal receiving pravastatin sodium tablets 80 mg daily, prescribe alternative LDL-C-lowering treatment The FDA drug label does not answer the question.

From the Research

Definition of High-Intensity Statins

High-intensity statins are defined as those that can reduce low-density lipoprotein cholesterol (LDL-C) by 50% or more 4, 5.

Examples of High-Intensity Statins

Examples of high-intensity statins include:

  • Rosuvastatin 20-40 mg 4, 6, 7
  • Atorvastatin 40-80 mg 4, 5, 6, 8

Comparison of High-Intensity Statins

Studies have compared the effects of different high-intensity statins on LDL-C reduction, including:

  • Rosuvastatin vs. atorvastatin: Rosuvastatin 20 and 40 mg were found to be more effective than atorvastatin 40 mg in reducing LDL-C 4
  • Atorvastatin vs. other statins: Atorvastatin was found to be more effective than fluvastatin, lovastatin, and pravastatin in reducing LDL-C, but less effective than simvastatin 8
  • Rosuvastatin vs. simvastatin and pravastatin: Rosuvastatin 10 mg was found to be more effective than simvastatin 20 mg and pravastatin 20 mg in achieving LDL-C goals 7

Patient Groups Benefiting from High-Intensity Statins

High-intensity statins are recommended for patient groups with:

  • Atherosclerotic cardiovascular disease (ASCVD) 4, 5
  • LDL-C ≥190 mg/dl 4
  • Diabetes 4
  • A 10-year ASCVD risk ≥7.5% 4
  • Severe hypercholesterolemia, diabetes with associated risk factors, and patients aged 40 to 75 years with a 10-year risk for ASCVD of 20% or greater 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.